PRRT2 and atherosclerosis: TMAO contributes to the early pathological process of atherosclerosis through accelerating endothelial activation and dysfunction, including reduced endothelial self-renewal and increased monocyte adhesion through activation of PKC/NF-κB/vascular cell adhesion molecule-1 (VCAM-1) [41].